The study reveals that moderate fever enhances CD4 T cell activity while reducing regulatory T cell suppression, highlighting ...

In a review of 32 mixed-type human studies, multinational researchers found a growing association between various classes of ...

Amgen (NASDAQ:AMGN) today announced TEPEZZA® (JAN: Teprotumumab (Genetical Recombination)) has been approved for the treatment of active or high ...

CureLab Veterinary Inc, a biopharmaceutical company that develops cancer treatments for pets, announced a Regulation D ...

But before you assume every stomach gurgle is sinister, know that it’s not super common in younger adults: There are one to ...

Crohn’s disease and ulcerative colitis, which are the most common types of inflammatory bowel disease (IBD), are more common ...